Sg Americas Securities, LLC Palatin Technologies Inc Transaction History

Sg Americas Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$0.47 - $0.64 $15,324 - $20,867	-32,606 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$0.41 - $0.73 $22,675 - $40,373	-55,306 Reduced 62.91%	32,606 $17,000
Q1 2020 Apr 30, 2020	BUY	$0.36 - $0.79 $23,934 - $52,523	66,486 Added 310.31%	87,912 $37,000
Q4 2019 Jan 28, 2020	BUY	$0.75 - $0.89 $8,420 - $9,992	11,227 Added 110.08%	21,426 $17,000
Q3 2019 Nov 04, 2019	SELL	$0.78 - $1.09 $2,691 - $3,760	-3,450 Reduced 25.28%	10,199 $9,000
Q2 2019 Jul 29, 2019	SELL	$0.98 - $1.64 $102,018 - $170,725	-104,101 Reduced 88.41%	13,649 $16,000
Q1 2019 Apr 29, 2019	BUY	$0.67 - $1.01 $78,892 - $118,927	117,750 New	117,750 $115,000
Q3 2018 Nov 06, 2018	SELL	$0.88 - $1.1 $62,956 - $78,695	-71,541 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$0.91 - $1.45 $65,102 - $103,734	71,541 New	71,541 $69,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $13.3M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.